Cidara Therapeutics, Inc. (CDTX)

Cidara Therapeutics Stock Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for Cidara Therapeutics stock have an average target of 4.67, with a low estimate of 3.00 and a high estimate of 6.00. The average target predicts an increase of 546.81% from the current stock price of 0.72.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$3.00	$4.67	$5.00	$6.00
Change	+315.51%	+546.81%	+592.52%	+731.02%

Analyst Ratings

The average analyst rating for CDTX stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '23	Dec '23	Jan '24	Feb '24	Mar '24	Apr '24
Strong Buy	2	2	2	2	2	2
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	3	3	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ed Arce HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $6	Strong Buy	Maintains	$6	+731.02%	Apr 8, 2024
Ed Arce HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $6	Strong Buy	Reiterates	$6	+731.02%	Dec 7, 2023
Ed Arce HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $6	Strong Buy	Reiterates	$6	+731.02%	Nov 6, 2023
Joseph Stringer Needham	Needham	Strong Buy Reiterates $3	Strong Buy	Reiterates	$3	+315.51%	Sep 22, 2023
Ed Arce HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $6	Strong Buy	Reiterates	$6	+731.02%	Sep 22, 2023

More Analyst Ratings

Financial Forecast

Revenue This Year

59.01M

Decreased by -8.22%

from 64.29M

Revenue Next Year

21.49M

Decreased by -63.57%

from 59.01M

EPS This Year

-0.31

from -0.43

EPS Next Year

-0.59

from -0.31

Year	2018	2019	2020	2021	2022	2023	2024	2025	2026	2027	2028
Revenue	-	20.92M	12.07M	49.57M	64.29M	59.01M	21.49M	46.98M	62.44M	112.07M	130.31M
Revenue Growth	-	-	-42.30%	310.81%	29.69%	-8.22%	-63.57%	118.58%	32.90%	79.49%	16.28%
EPS	-2.68	-1.37	-1.80	-0.81	-0.43	-0.31	-0.59	-0.13	0.05	0.54	0.68
EPS Growth	-	-	-	-	-	-	-	-	-	894.37%	25.47%
No. Analysts	-	-	-	-	-	6	6	5	5	5	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2023	2024	2025	2026	2027	2028
High	63.3M	31.0M	112.5M	139.2M	256.8M	193.0M
Avg	59.0M	21.5M	47.0M	62.4M	112.1M	130.3M
Low	51.9M	5.7M	9.1M	14.4M	34.2M	70.3M

Revenue Growth

Revenue Growth	2023	2024	2025	2026	2027	2028
High	-1.5%	-47.5%	423.6%	196.2%	311.4%	72.2%
Avg	-8.2%	-63.6%	118.6%	32.9%	79.5%	16.3%
Low	-19.2%	-90.4%	-57.6%	-69.3%	-45.2%	-37.3%

EPS Forecast

EPS	2023	2024	2025	2026	2027	2028
High	-0.29	-0.40	0.66	0.99	2.13	1.25
Avg	-0.31	-0.59	-0.13	0.05	0.54	0.68
Low	-0.35	-0.69	-0.61	-0.55	-0.38	0.14

EPS Growth

EPS Growth	2023	2024	2025	2026	2027	2028
High	-	-	-	-	3,820.6%	131.1%
Avg	-	-	-	-	894.4%	25.5%
Low	-	-	-	-	-	-74.6%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.